AGTC vs TVRD
Comparison between Applied Genetic Technologies Corp (AGTC, Company) and Cara Therapeutics Inc (TVRD, Company).
5-Year PerformanceAGTC has outperformed TVRD, delivering a return of -36.5% compared to -65.3%
AGTC vs TVRD - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
AGTC vs TVRD - Historical Returns
Returns include dividend reinvestment.
AGTC vs TVRD - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | AGTC | TVRD |
|---|---|---|
| 2026 | N/A | -35.54% |
| 2025 | N/A | -73.26% |
| 2024 | N/A | -32.57% |
| 2023 | N/A | -93.21% |
| 2022 | -80.89% | -15.10% |
| 2021 | -56.22% | -19.18% |
| 2020 | -1.45% | -2.01% |
| 2019 | +70.57% | +10.65% |
| 2018 | -33.60% | +1.25% |
| 2017 | -62.30% | +25.41% |
| 2016 | -52.78% | -44.34% |
| 2015 | -4.27% | +59.06% |
| 2014 | +42.41% | -22.77% |
AGTC vs TVRD Drawdown Comparison
The maximum drawdown for AGTC was -99.27%, occurring on Oct 20, 2022. This drawdown has not yet recovered.
The maximum drawdown for TVRD was -99.75%, occurring on Jun 17, 2026. This drawdown has not yet recovered.
The current AGTC drawdown is -98.76%. The current TVRD drawdown is -99.75%.
| Rank | AGTC | TVRD |
|---|---|---|
| #1 | -99.27% Jun 18, 2014 - Oct 20, 2022 | -99.75% Apr 9, 2021 - Jun 17, 2026 |
| #2 | -30.76% Apr 2, 2014 - Jun 2, 2014 | -80.50% Aug 5, 2015 - Jun 26, 2017 |
| #3 | -4.90% Jun 10, 2014 - Jun 12, 2014 | -66.16% Jun 28, 2017 - Apr 6, 2021 |
| #4 | -3.34% Jun 5, 2014 - Jun 9, 2014 | -65.50% Mar 5, 2014 - Aug 5, 2015 |
| #5 | -1.42% Mar 27, 2014 - Mar 31, 2014 | -17.89% Jan 31, 2014 - Feb 10, 2014 |
| #6 | -0.18% Jun 13, 2014 - Jun 17, 2014 | -4.33% Feb 18, 2014 - Feb 20, 2014 |
| #7 | N/A | -3.87% Feb 10, 2014 - Feb 18, 2014 |
| #8 | N/A | -3.47% Feb 21, 2014 - Feb 26, 2014 |
| #9 | N/A | -2.28% Apr 6, 2021 - Apr 8, 2021 |
Correlation
Correlation between AGTC and TVRD is -0.28 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks